PPARG and pulmonary emphysema: Various nuclear receptor agonists were reported to control neutrophil accumulation and the expression of MMP-9, and agonists of PPARγ and LXR exerted some anti-neutrophilic inflammatory and protective effects in the development of emphysema in a murine model [3].